Thalia Therapeutics Plc (AIM:THAT)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.6250
0.00 (0.00%)
Sep 4, 2026, 10:36 AM GMT

Thalia Therapeutics Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1.21-1.06-1.27-1.03-1.54
Asset Writedown & Restructuring Costs
-0.06---
Stock-Based Compensation
0.010.0100.020.02
Other Operating Activities
0.11-0.010.010.35-0.3
Change in Accounts Receivable
-0.05-0.010.04-0.040.01
Change in Accounts Payable
-0.030.040-0.130.04
Operating Cash Flow
-1.16-0.97-1.21-0.83-1.77
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Acquisitions
--0--
Investing Cash Flow
--0--

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
1.750.630.351.05-
Other Financing Activities
-0.14-0.06-0.03-0.090
Financing Cash Flow
1.610.570.320.960

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
0.45-0.4-0.890.14-1.77

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-0.68-0.68-0.77-0.54-1.38
Unlevered Free Cash Flow
-0.68-0.68-0.77-0.54-1.38

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.080.030.05-0.170.05